Success Story: Just 13 Business Days to EB-1B Approval for a Scientist Developing Tools for More Accurate Cancer Care
Client’s Testimonial:
"The team was exceptional, especially when it came to the reference letter stage. I faced some issues finding specific reference persons, but they were incredibly flexible and guided me through it without any stress. Their ability to handle my case so quickly—even over the holiday season—was impressive. I am very happy with the result and the seamless communication throughout the process.”
On January 13th, 2026, we received another EB-1B (Outstanding Professors and Researchers) approval for a Scientist in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Scientist
Country of Origin: Japan
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: January 13th, 2026
Processing Time: 13 business days (Premium Processing Requested)
Case Summary:
One independent expert captured the client’s impact in a single sentence:
“Overall, [Client] made an important contribution to the field of cancer biology by providing tools that improve the accuracy of diagnosis and treatment planning for patients with thyroid cancer.”
This EB-1B case moved quickly, but it did not rely on shortcuts. Our client, a cancer biology scientist from Japan, built a research profile around a practical question central to modern oncology: how do we turn complex tumor biology into information that clinicians and researchers can actually act on?The client’s work connects three areas: colorectal cancer, thyroid cancer, and immune-oncology. In colorectal cancer, the research links genetic patterns to long-term outcomes to improve risk grouping. In thyroid cancer, it sharpens diagnosis and treatment planning by distinguishing clinically meaningful tumor patterns. In immune-oncology, it uses spatial multi-omics to map immune activity inside tumors rather than relying on generalized assumptions.
Indicators of influence were strong and easy to corroborate. The record documented:
- 48 peer-reviewed journal articles
- 6 conference abstracts
- 1 preprint
- 3 first-authored book chapters
- 1 letter to the editor
Recognition also appeared in the “peer trust” channels that matter in EB-1B review. The client had completed at least 30 peer reviews for respected journals, indicating that editors considered her judgment reliable enough to evaluate others’ work. Unsolicited invitations to speak at major conferences reinforced that the broader community viewed the research as something to feature, not simply to file away.
USCIS approved the EB-1B petition in 13 business days with Premium Processing. NAILG supported a presentation that kept the story simple: clinically meaningful questions, technically rigorous answers, and independent signs that the field is already using and building on the client’s work.